MedTrace Logo

Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia

NCT00928291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-06-23

No results posted yet for this study

Summary

In this study the investigators aim to test if a procalcitonin (PCT) - guided strategy allows to reduce the antibiotic use in patients with febrile neutropenia hospitalized in a Brazilian tertiary university hospital, causing no harm.

Conditions

Interventions

OTHER

procalcitonin

plasma PCT measurement

DRUG

antibiotic therapy

antibiotic therapy use

Sponsors & Collaborators

  • Federal University of Minas Gerais

    lead OTHER

Principal Investigators

  • Vandack Nobre, PhD · Medicine Faculty of Federal University of Minas Gerais

  • Stella SS Lima, MD · Medicine Faculty of Federal University of Minas Gerais

  • Henrique NS Bittencourt, PhD · Medicine Faculty of Federal University of Minas Gerais

  • José C Serufo, PhD · Medicine Faculty of Federal University of Minas Gerais

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00928291 on ClinicalTrials.gov